Evidence map›Paper›PMID 22713773›Full record

Trial reportEuropean journal of clinical nutrition2012

Urinary estrogen metabolites in two soy trials with premenopausal women.

G Maskarinec, Y Morimoto, S Heak, M Isaki, A Steinbrecher, L Custer, A A Franke

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in European journal of clinical nutrition, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

G MaskarinecUniversity of Hawaii Cancer Center, Honolulu, HI 96813, USA. gertraud@cc.hawaii.edu
Y Morimoto
S Heak
M Isaki
A Steinbrecher
L Custer
A A Franke

Funding

University of Hawaii Cancer Center CCSGP30CA071789 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI GERTRAUD MASKARINEC · 1996 to 2026
$56.2M
SOY EFFECTS ON ESTROGENS AND MAMMOGRAPHIC DENSITIESR01CA080843 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI MASKARINEC, GERTRAUD · 1999 to 2010
$2.9M
MASS SPECT SYST: SOY PHYTOESTROGEN &CARDIOVASCULAR EFFECTS, ATHEROSCLEROSISS10RR020890 · NCRR · UNIVERSITY OF HAWAII AT MANOA · PI FRANKE, ADRIAN A · 2005 to 2005
$421k
NCI NIH HHS P30 CA071789NCI NIH HHS P30 CA71789NCI NIH HHS R01 CA080843NCI NIH HHS R01 CA 80843NCRR NIH HHS S10 RR020890
6 · The paper itself

Abstract

backgroundSoy consumption may protect against breast cancer through modification of estrogen metabolism.

objectivesWe examined the effect of soy foods on urinary estrogens and the 2-hydroxy (OH)/16α-OH estrone (E(1)) ratio in two dietary interventions with premenopausal women. SUBJECTS/

methodsThe Breast, Estrogens, And Nutrition (BEAN1) study was a 2-year randomized trial and BEAN2 a 13-month randomized crossover study. In both interventions, study participants consumed a high-soy diet with 2 soy food servings/day and a low-soy diet with <3 servings of soy/week. Urine samples were collected at baseline and at the end of the diet periods, analyzed for nine estrogen metabolites by liquid chromatography mass spectrometry, and adjusted for creatinine levels. For BEAN1, two samples for 188 participants and for BEAN2, three samples for 79 women were analyzed. We applied mixed-effects regression models with log-transformed values of estrogen metabolites and soy intake as the exposure variable.

resultsIn BEAN1, no effect of the high-soy diet on individual estrogen metabolites or hydroxylation pathways was observed. The median 2-OH/16α-OHE(1) ratio decreased non-significantly in the intervention group from 6.2 to 5.2 as compared with 6.8 and 7.2 in the control group (P=0.63). In BEAN2, only 4-OHE(1) was significantly lower after the high-soy diet. Interaction terms of the high-soy diet with equol producer status, ethnicity and weight status revealed no significant effect modification.

conclusionsContrary to our hypothesis and some previous reports, the results from two well-controlled dietary interventions do not support an effect of a high-soy diet on a panel of urinary estrogen metabolites and the 2-OH/16α-OHE(1) ratio.

Indexed as

Soy FoodsAdultChromatography, LiquidCross-Over StudiesDietEstrogensFemaleHumansHydroxyestronesIsoflavonesMass SpectrometryPremenopauseRegression Analysis16-hydroxyestrone2-hydroxyestroneEstrogensHydroxyestronesIsoflavones

Identifiers

PMID22713773
PMCPMC3437012

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.